ATHEROGENICS INC 4
4 · ATHEROGENICS INC · Filed Jun 16, 2005
Insider Transaction Report
Form 4
ATHEROGENICS INCAGIX
ATTICUS CAPITAL LLC
10% Owner
Transactions
- Purchase
Common Stock
2005-06-14$16.32/sh+50,000$816,000→ 3,915,700 total(indirect: See Note)
Footnotes (1)
- [F1]Mr. Barakett, who is an additional Reporting Person, is the Chairman, Chief Executive Officer, and Managing Member of Atticus Capital, L.L.C., a Delaware limited liability company ("Atticus Capital"). Atticus Capital and certain of its affiliated entities (collectively, the "Atticus Entities") act as advisers for various investment funds (the "Funds") and managed accounts (the "Accounts"). Based on his relationship with the Atticus Entities, Mr. Barakett is deemed to be a beneficial owner of the Securities owned by the Funds and the Accounts for purposes of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934. Mr. Barakett and Atticus Capital disclaim beneficial ownership within the meaning of Rule 16a-1(a)(2) under the Securities Exchange Act of 1934 in the Securities owned by the Funds and the Accounts except to the extent, if any, of their pecuniary interest therein.